ICU Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 02, 2026
Report Source: 2025 Annual Report
SeaStar Medical Holding Corp. Stock Analysis ICU
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company is headquartered in Denver, Colorado and currently employs 17 full-time employees. The company went IPO on 2021-01-26. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. The company has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
Read More SeaStar Medical Holding Corp (ICU) Chart
Key Statistics of SeaStar Medical Holding Corp (ICU)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$4.21Volume
65.18KP/E Ratio (TTM)
-52 Week Range
Market Cap
17.65MAvg. Volume
89.22KDividend Yield
-Financial Metrics & Statements of SeaStar Medical Holding Corp (ICU)
FAQ's for SeaStar Medical Holding Corp (ICU)
- According to Musaffa’s Shariah screening methodology, SeaStar Medical Holding Corp (ICU) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.